PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, ACTREC - Tata Memorial Centre, Navi Mumbai, Maharashtra, India.\', \'Homi Bhabha National Institute, Mumbai, Maharashtra, India.\', \'Department of Anaesthesiology, Pain and Critical Care Medicine, ACTREC - Tata Memorial Centre, Navi Mumbai, Maharashtra, India.\', \'Department of Hemato-Pathology, ACTREC - Tata Memorial Centre, Navi Mumbai, Maharashtra, India.\', \'Department of Radiodiagnosis, ACTREC - Tata Memorial Centre, Navi Mumbai, Maharashtra, India.\', \'Department of Laboratory Medicine, ACTREC - Tata Memorial Centre, ACTREC, Navi Mumbai, Maharashtra, India.\', \'Department of Microbiology, ACTREC - Tata Memorial Centre, ACTREC, Navi Mumbai, Maharashtra, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/tid.13576
?:hasPublicationType
?:journal
  • Transplant infectious disease : an official journal of the Transplantation Society
is ?:pmid of
?:pmid
?:pmid
  • 33523551
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all